On August 29, 2019 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, reported that members of the management team will participate in the following upcoming investor conferences (Press release, Pieris Pharmaceuticals, AUG 29, 2019, View Source [SID1234539113]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi 14th Annual Biotech Conference

Wednesday, September 4, 2019 at the Four Seasons Hotel in Boston. The Company will conduct one-on-one meetings with institutional investors at this conference.

Baird 2019 Global Healthcare Conference

Thursday, September 5, 2019 at 2:00PM EDT at the InterContinental New York Barclay Hotel in New York City. A webcast of the Company’s presentation will be available at this link.

H.C. Wainwright 21st Annual Global Investment Conference

Monday, September 9, 2019 at 9:10AM EDT at the Lotte New York Palace Hotel in New York City. A webcast of the Company’s presentation will be available at this link.